ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

Obey Attacks NCI, Eppley, Shubick, Asks for Full Report From GAO

June 10, 1977

AIDS Research Loan Repayment Program

January 10, 1992

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

In Brief: Kennedy Drops Health Care Institute Plan Senate Approves Dole Amendment On Patents

August 18, 1978

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011